Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Reprod Toxicol ; 60: 112-22, 2016 04.
Artículo en Inglés | MEDLINE | ID: mdl-26867865

RESUMEN

Cisplatin (CP) is used to treat a number of cancers, including testicular cancer. Studies indicate that CP-treatment can impair spermatogenesis in humans and rodents by germ cell DNA binding, through different modes of action. CP-paternal exposure resulted in adverse effects in F1 male offspring. In this study, F1 female offspring was assessed for reproductive development after CP-paternal exposure. Peri-pubertal male rats, treated with 1mg/Kg/day of CP or vehicle for 3 weeks, were mated with unexposed females. F1 female offspring of CP-treated fathers showed a decrease in fetal ovary germ cells, in estrous cycle length and FSH levels, and an increase in the percentage of antral follicles in adults. Based on our previous results and the findings of the present work we concluded that CP-paternal exposure leads to adverse effects on rat male and female reproductive development, raising concern, in humans, for children born to men exposed to CP.


Asunto(s)
Antineoplásicos/toxicidad , Cisplatino/toxicidad , Exposición Paterna , Efectos Tardíos de la Exposición Prenatal , Diferenciación Sexual/efectos de los fármacos , Animales , Ciclo Estral/efectos de los fármacos , Femenino , Fertilidad/efectos de los fármacos , Hormona Folículo Estimulante/sangre , Células Germinativas/efectos de los fármacos , Masculino , Ovario/efectos de los fármacos , Embarazo , Ratas Wistar , Conducta Sexual Animal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA